Skip to content
OpenCapital
Get started

Sylvamo SLVM Cumulative Gross Losses and Impairments

Cumulative Gross Losses and Impairments at other companies

International Paper logo
International PaperIP
$2.6B+1,291%

Segments

By segment

See full
Europe Segment$13M+1,200%
Latin America Segment$0—
North America Segment$0—

Other financials

Income statement

See full
Revenue$755.0M-8.0%
Gross profit$125.0M-21.4%
Net income-$3.0M-111%
EPS (diluted)-$0.08-112%

Balance sheet

See full
Cash & equivalents$130.0M-15.6%
Total debt$861.0M-3.9%
Total equity$979.0M+7.8%
Total assets$2.8B+2.6%

Cash flow

See full
Operating cash flow-$10.0M-143%
CapEx$49.0M+2.1%
Free cash flow-$59.0M-136%

Valuation

See full
Market cap$1.58B-38.6%
Enterprise value$2.31B-30.7%
P/E15.5×+6.5×
P/S0.5×-0.2×

Profitability

See full
Gross margin21.3%-3.3pp
Net margin3.1%-4.6pp
FCF margin0.3%-6.6pp

Returns & leverage

See full
Return on equity10.8%-21.0pp
Debt / equity0.9×-0.1×
Current ratio1.4×-0.2×

Where this comes from

Reported directly by Sylvamo in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The official record: Sylvamo’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sylvamo's cumulative gross losses and impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sylvamo's cumulative gross losses and impairments?
Sylvamo (SLVM) reported cumulative gross losses and impairments of $13M in Q1 2026.
How has Sylvamo's cumulative gross losses and impairments changed year-over-year?
Sylvamo's cumulative gross losses and impairments increased by 1200.0% year-over-year, from $1M to $13M.
What is the long-term trend for Sylvamo's cumulative gross losses and impairments?
Over 5 years (2020 to 2025), Sylvamo's cumulative gross losses and impairments has grown at a 67.0% compound annual growth rate (CAGR), from $1M to $13M.
What does cumulative gross losses and impairments mean?
This metric aggregates all unrealized losses and recognized impairment charges on investment securities that have not yet been realized through a sale. It provides a comprehensive view of the negative valuation adjustments impacting the bank's equity. It is a key indicator of the credit and market risk embedded in the bank's long-term holdings.